Abbott is moving to acquire Exact Sciences, a molecular diagnostics company that specializes in the detection of early-stage ...
SALT LAKE CITY, Oct. 6, 2025 /PRNewswire/ -- bioMérieux, a global leader in in vitro diagnostics, and Henry Ford Health partnered to host the Summit, held Sept. 30–Oct. 1 at the Westin Detroit ...
After the deal closes, Abbott says Exact Sciences will maintain its presence in Madison. Exact Sciences CEO Kevin Conroy will ...
Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highlight growth and valuation momentum.